CrisprBits Non-public Restricted, a biotechnology startup, has inaugurated a CRISPR gene enhancing and diagnostics laboratory in Bengaluru.
The brand new facility consists of superior infrastructure laboratory options with devoted areas for lyophilisation (a course of used to maintain reagents secure at room temperature), cell and tissue tradition, bacterial tradition, molecular biology analysis, and cleanroom operations.
Moreover, the laboratory features a specialised gene enhancing part and a tissue tradition space designed to help stem cell analysis.
The CrisprBits innovation centre includes a state-of-the-art Laboratory Info Administration System (LIMS) and superior clever programs for the sensible design of CRISPR guides, finishing its cutting-edge expertise platforms.
Talking in regards to the launch of the brand new facility, Vijay Chandru, co-founder & director of CrisprBits, mentioned, “The state-of-the-art CRISPR gene enhancing laboratory and diagnostics will higher equip us to fulfill essential wants and develop options which have vital business and social influence.”
CrisprBits was based in 2020 by Vijay Chandru, Sunil Arora, Rajeev Kohli, Bharat Jobanputra, and Aditya Sarda with a imaginative and prescient of innovating for the well-being of people and the planet.
The ladies-led government and scientific crew comprising Vaijayanti Gupta, Reety Arora, and Vandana Hegde has a formidable observe file in genomic science, molecular diagnostics, and gene enhancing.
Below the steerage of the founding crew and an distinctive science advisory board, the crew goals to drive the corporate towards new purposes of CRISPR expertise.
Incubated initially on the Middle for Mobile and Molecular Platforms (CCAMP) for the previous 4 years, the startup has been specializing in creating a speedy point-of-need molecular diagnostics platform.
Within the subsequent few months, CrisprBits goals to launch a number of key checks in inexpensive uncommon illness diagnostics and hospital-acquired infections (HAI), together with antimicrobial resistance checks utilizing the platform.
CrisprBits will proceed its operations at CCAMP shortly on a number of collaborative gene enhancing initiatives.
Over the subsequent six months, it plans to introduce novel purposes of CRISPR in constructing iPSC (induced pluripotent stem cell) fashions for uncommon illnesses. Focused enhancing of cell strains and microbes vital for industrial microbiology purposes can be in progress.
CrisprBits’s OmiCrisp
Earlier in 2024, CrisprBits launched OmiCrisp, a CRISPR-based testing platform designed for speedy prognosis and surveillance of SARS-CoV2. The startup talked about that OmiCrisp’s functionality is just not solely to detect the virus but in addition to tell apart variants of the Omicron lineage from different identified variants of concern.
A complete research, performed with help from Blockchain for Influence, validated OmiCrisp with spectacular outcomes. The research showcased OmiCrisp’s effectiveness in discerning single-base modifications even in poor-quality sewage samples.
The CRISPR-based check demonstrated a outstanding 99% accuracy in detecting the Omicron lineage in each medical and wastewater samples.
The put up CrisprBits Opens CRISPR Gene Enhancing Centre in Bengaluru appeared first on Analytics India Journal.